ProEn Therapeutics Inc. announced that it has received funding from new investor Kolmar Korea Holdings Co., Ltd. on March 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,750 KRW | +5.68% | +4.79% | +10.76% |
05-06 | Kolmar Group Vice Chairman Appointed as CEO of Kolmar Holdings | MT |
04-03 | Intercos clarifies its position in lawsuit over Kolmar and Intercos Korea | AN |
1st Jan change | Capi. | |
---|---|---|
+10.76% | 235M | |
+16.80% | 8.43B | |
+7.94% | 7.8B | |
+15.02% | 6.82B | |
-4.77% | 3.77B | |
-6.75% | 3.74B | |
+4.41% | 1.44B | |
-30.34% | 1.06B | |
+20.28% | 1.04B | |
-12.85% | 890M |
- Stock Market
- Equities
- A024720 Stock
- News Kolmar Holdings Co.,Ltd.
- ProEn Therapeutics Inc. announced that it has received funding from Kolmar Korea Holdings Co., Ltd.